Cosmo Pharmaceuticals N.V. (CMOPF)
OTCMKTS · Delayed Price · Currency is USD
151.00
-4.00 (-2.58%)
At close: Feb 11, 2026
Cosmo Pharmaceuticals Market Cap
Cosmo Pharmaceuticals has a market cap or net worth of $2.38 billion as of February 12, 2026. Its market cap has increased by 106.22% in one year.
Market Cap
2.38B
Enterprise Value
2.24B
Revenue
214.06M
Ranking
n/a
PE Ratio
33.85
Stock Price
$151.00
Market Cap Chart
Since March 12, 2007, Cosmo Pharmaceuticals's market cap has increased from 159.09M to 2.38B, an increase of 1,398.83%. That is a compound annual growth rate of 15.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 2.38B | 12.43% |
| Dec 30, 2025 | 2.12B | 88.21% |
| Dec 30, 2024 | 1.13B | 15.97% |
| Dec 29, 2023 | 971.74M | -10.39% |
| Dec 30, 2022 | 1.08B | -10.26% |
| Dec 30, 2021 | 1.21B | -13.15% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 766.76M |
| Glass House Brands | 737.37M |
| Elite Pharmaceuticals | 473.68M |
| Nika Pharmaceuticals | 403.38M |
| Northwest Biotherapeutics | 399.44M |
| American Oncology Network | 377.98M |
| OpGen | 340.99M |
| CytoDyn | 311.51M |